Global DNA Vaccines Market is experiencing rapid growth owing to
the factors such as the property of specific antigen targeting, reduced risk of
infection compared to conventional vaccines and improved stability. Moreover,
relative ease of large-scale manufacturing compared to traditional approach and
less storage requirement are some of the key market drivers.
A DNA vaccine is a small, circular DNA plasmid that encode one
or more protein antigens under the control of a promoter to produce immune
response against disease. DNA vaccines are basically the third generation
vaccines that are specifically designed to overcome the unsought properties of
conventional vaccines. The increasing vulnerability of population to infectious
diseases and increasing number of antibiotics resistant pathogens have created
the need for effective and low-cost vaccination, which would provide long
lasting immunity. DNA vaccines have potential advantages over traditional
methods, e.g., low risk of infection, easy transportation and stability at room
temperature.
Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/671
Companies profiled in the report includes
·
Sanofi Aventis
·
Pfizer Pharmaceuticals
·
Novartis AG
·
Merck & Co.
·
GlaxoSmithKline Inc.
·
Advance Bioscience Laboratories Inc.
·
Indian Immunologicals Ltd.
·
Xenetic Biosciences Inc.
·
QED Biosciences Inc.
According to World Health Organization, ~18 million people die
due to the unavailability of effective treatment for infectious disease, which
demonstrate global burden of infectious disease. Thus, the increasing burden of
these diseases reveals the opportunity for DNA vaccines manufacturers.
Moreover, rapid development in the field of molecular biology, immunology and
DNA synthesis would further drive the growth of this market. Other factors such
as inefficient drug therapies and increased microbial resistance to existing
‘antimicrobials and antibiotics’ treatments would likely to create the demand
for DNA vaccines in near future.
The global DNA vaccines market is segmented based on type,
technology, application, end user and geography. Based on type, the market is
further segmented into human DNA vaccines and animal DNA vaccines. Based on
technology, the DNA vaccines market is further segmented into DNA vaccine
technology and DNA delivery technology. Based on applications, the market is
further segmented into human disease i.e., oncology, infectious disease,
allergies and others; and veterinary diseases i.e. Canine Melanoma,
Leishmaniasis, Equine West Nile Virus, and others. Based on end user, the
market is segmented into human health, animal health and research application.
Based on geography, the market is segmented into North America, Europe,
Asia-Pacific and LAMEA.
For More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/671
KEY MARKET BENEFITS
- Comprehensive analysis of factors that
drive and restrict the growth of the global DNA vaccines market is
provided in the report.
- The report provides quantitative analysis
of the current market and estimations through 2014‐2020 that assists in
identifying the prevailing market opportunities to capitalize on
- DNA vaccines market conditions are
comprehensively analyzed based on region and country.
- Key market players within the DNA
vaccines market are profiled in the report and their strategies are
analyzed thoroughly, which help in understanding competitive outlook of
the market
- Extensive analysis of the market is
conducted by closely following key product positioning and monitoring the
top contenders within the market framework
- Exhaustive analysis of the global DNA
vaccines market by application helps in understanding DNA vaccines that
are currently being used along with the variants that would gain
prominence in the future
Access Full Summery @ https://www.alliedmarketresearch.com/DNA-vaccines-market
No comments:
Post a Comment